Nesidioblastosis
| Nesidioblastosis | |
|---|---|
| Synonyms | Congenital hyperinsulinism, Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hypoglycemia, seizures, lethargy, poor feeding |
| Complications | Neurological damage, developmental delay |
| Onset | Infancy |
| Duration | Chronic |
| Types | N/A |
| Causes | Beta cell hyperplasia in the pancreas |
| Risks | Genetic predisposition, mutations in ABCC8 or KCNJ11 genes |
| Diagnosis | Blood tests, insulin levels, genetic testing, pancreatic biopsy |
| Differential diagnosis | Insulinoma, Beckwith-Wiedemann syndrome, congenital adrenal hyperplasia |
| Prevention | N/A |
| Treatment | Diazoxide, octreotide, pancreatectomy |
| Medication | Diazoxide, octreotide |
| Prognosis | Variable, depends on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Nesidioblastosis is a rare medical condition characterized by the overproduction of insulin due to the enlargement of the beta cells in the pancreas. This condition is most commonly diagnosed in infants and children, but can also occur in adults. The excessive insulin production can lead to persistent hypoglycemia (low blood sugar levels).
Symptoms[edit]
The primary symptom of nesidioblastosis is hypoglycemia, which can manifest as:
- Trembling or shakiness
- Sweating
- Rapid heartbeat
- Blurred vision
- Dizziness or lightheadedness
- Hunger
- Irritability or moodiness
- Fatigue or weakness
- Headache
Causes[edit]
The exact cause of nesidioblastosis is unknown, but it is believed to be related to genetic mutations. Some cases have been associated with specific genetic disorders, such as Beckwith-Wiedemann syndrome and Turner syndrome.
Diagnosis[edit]
Diagnosis of nesidioblastosis typically involves blood tests to measure insulin and glucose levels. Imaging tests, such as a CT scan or MRI, may be used to visualize the pancreas. In some cases, a biopsy of the pancreas may be necessary.
Treatment[edit]
Treatment for nesidioblastosis typically involves medications to manage blood sugar levels. In severe cases, partial or total removal of the pancreas (pancreatectomy) may be necessary.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



